MaxQuant


Mass Spectrometry-Proteomics
Oncology Research
Multitasking and Organization
Attention to Detail
Interpersonal and Social Skills
MaxQuant
Proteome Discoverer
R studio
MSFragger
Perseus
Co-reviewer: Nature Communications Manuscript Submissions
Committee Member: Department Chair Search Committee
Program Representative: Council of Graduate Students
Graduate student mentor
LC-MS/MS Instrumentation: Agilent 1260 Infinity HPLC, Ultimate 3000 RSLCnano, Q Exactive Plus, Orbitrap Velos, Orbitrap Fusion
Assays: cell viability (sulforhodamine B, MTT), protein quantitation (BCA, Pierce660, Bradford), western blot, HDAC activity
1. Duda JM and Thomas SN. “Histone Deacetylase 6 with DNA damage repair factors strengthens its utility as a combination drug target in high-grade serous ovarian cancer” (2023) ACS Pharmacology & Translational Science. 6(12) 1924-1933. PMID: 38107255. PMCID: PMC10723650
2. Duda JM, Twigg CAI, and Thomas SN. “Differential histone deacetylase inhibitor-induced perturbations of the global proteomic landscape in the setting of high-grade serous ovarian cancer.” (2022). Proteomics. 23(3-4). PMID: 36193784. PMCID: PMC995782
3. Duda JM and Thomas SN. “Combination of SILAC and substrate trapping for the detection of transient protein interactions.” (2022). Methods in Molecular Biology. Luque-Garcia JL, editor. Springer Nature. Vol. 2603. pp. 219-234. PMID: 36370283
4. Auerbach AA, Becker JT, Moraes SN, Moghadasi SA, Duda JM, Salamango DJ, Harris RS. “Ancestral APOBEC3B Nuclear Localization Is Maintained in Humans and Apes and Altered in Most Other Old World Primate Species” (2022). mSphere. 7(6). PMID: 36374108. PMCID: PMC9769932.